Chandel Lab

Navdeep Chandel, PhD, the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and Critical Care and of Biochemistry and Molecular Genetics,  has been named a recipient of the 2023 Lurie Prize in Biomedical  Sciences by the Foundation for the National Institutes of Health (FNIH).

...

For more information about the Lurie Prize in Biomedical Sciences and a list of previous winners, please visit fnih.org/LuriePrize.

Dr. Chandel discusses a recent study that may improve the understanding of mitochondrial dysfunction and its impact on the development of neurological diseases. The study, led by Greg McElroy, also suggests that targeting mitochondrial complex I linked biology could be a promising therapeutic target for neurological diseases.

Northwestern Medicine investigators have discovered that mitochondria  regulate essential cellular signaling for the development of epithelial  cells in the lungs, cells which are crucial for the exchange of oxygen  and carbon dioxide to avoid respiratory failure, according to findings published in Nature.

...

Dr. Chandel discusses recent publications in the lab demonstrating the essential role of the mitochondrial electron transport chain in tumorigenesis and potential therapeutic avenues for targeting mitochondrial metabolism in the clinic.

Twelve faculty with appointments at Feinberg, including Nav Chandel, were named to the 2022 “Highly Cited Researchers”  list, published by Clarivate Analytics. The annual list identifies  investigators who have demonstrated significant influence in their  field through the publication of highly cited publications during the  last decade.

The data in the list is pulled from papers published in science and  social sciences journals from 2011 through 2021. The list includes those  investigators who rank among the top one percent as the most cited for  their subject field and year of publication.